LOS ANGELES–(BUSINESS WIRE)–$ADCT #ADCT—The Schall Legislation Agency, a nationwide shareholder rights litigation agency, proclaims that it’s investigating claims on behalf of traders of ADC Therapeutics SA (“ADC” or “the Firm”) (NYSE: ADCT) for violations of the securities legal guidelines.
The investigation focuses on whether or not the Firm issued false and/or deceptive statements and/or didn’t disclose info pertinent to traders. ADC was the topic of a Morgan Stanley downgrade on September 9, 2022, from “chubby” to “equal weight.” Analysts cited considerations in regards to the Firm’s market penetration with its Zynlonta product. Based mostly on this information, shares of ADC dropped by greater than 5% on the identical day.
In case you are a shareholder who suffered a loss, click on right here to take part.
We additionally encourage you to contact Brian Schall of the Schall Legislation Agency, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to debate your rights freed from cost. You can too attain us by way of the agency’s web site at www.schallfirm.com, or by electronic mail at [email protected].
The category on this case has not but been licensed, and till certification happens, you aren’t represented by an legal professional. When you select to take no motion, you possibly can stay an absent class member.
The Schall Legislation Agency represents traders world wide and focuses on securities class motion lawsuits and shareholder rights litigation.
This press launch could also be thought of Lawyer Promoting in some jurisdictions beneath the relevant regulation and guidelines of ethics.
Contacts
The Schall Legislation Agency
Brian Schall, Esq.
310-301-3335
[email protected]www.schallfirm.com
